Seventh annual Orphan Drugs and Rare Diseases UK

Event Date
-
Location

Holiday Inn Kensington Forum
97 Cromwell Road
London
SW7 4DN
United Kingdom

An increasing number of pharmaceutical companies, both large and small, are developing drugs for rare diseases, also known as orphan drugs because of their special status within the regulatory system. This meeting will discuss some of the opportunities and challenges facing companies developing orphan drugs. Some industry analysts expect the market for orphan drugs to grow to $127 billion by 2018.

If so, this remains a significant market opportunity. This meeting will cover topics such as recruiting patients into trials of experimental orphan drugs, building strategic partnerships with other companies and understanding the landscape for pricing and reimbursement.